A claim circulating online suggests that Alexander Zverev’s girlfriend, Sophia Thomalla, has unexpectedly announced that the German tennis player tested positive for an illness. The statement has attracted attention because
it presents the alleged test result as a recent development. However, no reliable official confirmation of such an announcement has been identified.
Neither Zverev nor Thomalla has been found to have publicly confirmed such a test result in the current information available. There is also no corresponding announcement from the ATP Tour or another official tennis organization confirming that the 29-year-old has recently tested positive for a disease.
The distinction is important because health information concerning a professional athlete should not be presented as fact unless it comes from the athlete, an authorized representative, a medical announcement, or another authoritative source. In this case, the available evidence does not establish that the alleged announcement actually occurred.
Recent coverage instead shows Zverev continuing to be closely associated with professional tennis following one of the most successful periods of his career. In 2026, he won his first Grand Slam title at Roland-Garros before continuing his season at the highest level of the ATP Tour.
Zverev was born in Hamburg on April 20, 1997, and has spent much of his professional career among the leading players in men’s tennis. The ATP has documented his rise
from a young professional to one of the established figures on the tour, including his long-standing presence near the top of the world rankings.
One of the most significant confirmed developments in his career came at the 2026 French Open. Zverev defeated Flavio Cobolli in the final at Roland-Garros to claim his first Grand Slam singles championship.
The Laver Cup subsequently described the achievement as the completion of a major objective that had remained outstanding during his career.
His 2026 season has also included continued discussion of his management of Type 1 diabetes. Zverev has been open about being diagnosed with the condition when he was four years
old, and his foundation has focused on helping children and families affected by diabetes. The condition is therefore established public information, rather than a newly reported diagnosis.
During matches, Zverev monitors his blood glucose levels and manages his diabetes as necessary. The Associated Press reported during Wimbledon that his condition requires regular monitoring and, when needed, insulin.
These details relate to his established medical history and should not be confused with the unverified claim about a new positive test.
The Alexander Zverev Foundation was established in 2022 with a focus on diabetes awareness and support for children affected by the condition. His decision to speak publicly about Type 1 diabetes has helped make the subject part of his public profile, particularly when discussing the practical demands of professional sport.
There is also confirmed information about Zverev’s relationship with Sophia Thomalla. The couple made their relationship public in 2021, and Thomalla has regularly shown support for him during major tournaments. Recent reports documented her reaction following Zverev’s success at the 2026 US Open.
After Zverev’s US Open victory in September, Thomalla shared a message celebrating his achievement. Reports said she was not present in the stadium for the final but congratulated him through social media. The documented message concerned his sporting success and did not constitute an announcement about a new medical diagnosis.
The couple has generally maintained a degree of privacy regarding their personal lives, although Zverev has spoken publicly about their relationship. In a 2026 interview, he described Thomalla as an important source of support and discussed his hopes for the future, including his wish for a large family.
During that conversation, Zverev also discussed a difficult period earlier in 2026. He said that people close to him, including his parents, coaching team and partner, had noticed changes in his mood and behavior. He explained that he had received professional support and felt that his situation had improved.
Those comments were made by Zverev himself and are therefore different from the current claim about a positive medical test. They provide documented information about his own description of a difficult period, but they do not establish that he has recently contracted an illness or received a positive test result.
His professional schedule also provides relevant context. The Laver Cup described Zverev as a regular member of Team Europe and confirmed that he was preparing to compete in London in September 2026. The tournament noted his Grand Slam breakthrough and his continued role as one of Europe’s leading players.
The available information therefore does not support the suggestion that his girlfriend recently made a confirmed announcement about a positive test. While social-media posts can spread rapidly, the wording of such posts alone cannot establish the authenticity of a medical claim.
This is particularly important when the alleged information concerns a person’s health. A positive medical test could refer to many different conditions, and without knowing what was allegedly tested, when the test occurred, who administered it, or who confirmed the result, it would be inappropriate to identify a diagnosis.
There is currently no verified basis for adding such details to the story. The available sources instead confirm Zverev’s recent sporting activities, his established Type 1 diabetes diagnosis, his relationship with Thomalla, and his continued involvement in professional tennis during 2026.
The distinction between a confirmed diagnosis and an unverified report is particularly relevant for Zverev because his health has previously been discussed publicly. His Type 1 diabetes is well documented, but that does not mean every subsequent claim involving a test or illness should automatically be connected to that condition.
Similarly, Thomalla’s public support for Zverev does not establish that she has announced private medical information on his behalf. Recent reporting about her public messages has focused on his tennis performances and their relationship rather than a newly confirmed health development.
Zverev’s 2026 season has otherwise provided substantial confirmed sporting developments. His French Open triumph represented his first major singles title, while his participation in the Laver Cup followed another demanding stretch of the professional calendar. The tournament described him as a key member of Team Europe.
His career has also been shaped by earlier physical challenges. The Laver Cup has documented his serious ankle injury at the 2022 French Open and his return to competition approximately six months later.
That recovery became an important part of his professional story before his eventual Grand Slam breakthrough in 2026.
For that reason, any new health announcement involving Zverev would normally be significant and should be supported by clear documentation. At present, however, no such documentation has been identified for the alleged positive test attributed to Sophia Thomalla.
The responsible conclusion is therefore limited to what can be established. Alexander Zverev remains a professional tennis player who has publicly discussed his Type 1 diabetes and has continued competing at the highest level.
Sophia Thomalla remains his publicly known partner, and she has recently congratulated him on his tennis achievements.
There is no verified evidence in the sources reviewed that Thomalla has announced a new positive medical test involving Zverev. Until an official statement or a direct, verifiable announcement becomes available, the claim should remain unconfirmed rather than being presented as a medical fact.
The confirmed picture is therefore one of an athlete continuing his professional career after a landmark 2026 season, while openly managing a long-established health condition. Any future announcement concerning his
health should be evaluated on the basis of the original statement and the authority of the source before being treated as confirmed information.